174 related articles for article (PubMed ID: 8610217)
21. [Sjögren's syndrome and malignant lymphoma].
Wu X; Huang Y; Li G
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):326-8. PubMed ID: 10684105
[TBL] [Abstract][Full Text] [Related]
22. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
[TBL] [Abstract][Full Text] [Related]
23. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
Anaya JM; McGuff HS; Banks PM; Talal N
Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
[TBL] [Abstract][Full Text] [Related]
25. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
[TBL] [Abstract][Full Text] [Related]
26. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
Opriş D; Iosif CI; Predeţeanu D
Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
[TBL] [Abstract][Full Text] [Related]
27. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
[TBL] [Abstract][Full Text] [Related]
28. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
Nagai K
Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
[TBL] [Abstract][Full Text] [Related]
29. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
[TBL] [Abstract][Full Text] [Related]
30. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
31. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
32. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
33. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome.
Voulgarelis M; Dafni UG; Isenberg DA; Moutsopoulos HM
Arthritis Rheum; 1999 Aug; 42(8):1765-72. PubMed ID: 10446879
[TBL] [Abstract][Full Text] [Related]
34. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
Le Guern V; Mouthon L
Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
[TBL] [Abstract][Full Text] [Related]
35. Non-Hodgkin's lymphomas complicating Sjögren's syndrome: can Epstein Barr virus be implicated?
Jeffers M; Crilly A; Kerr T; Richmond J; Madhok R
Scand J Rheumatol; 1997; 26(3):180-3. PubMed ID: 9225872
[TBL] [Abstract][Full Text] [Related]
36. [The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome].
Vasil'iev VI; Logvinenko OA; Probatova NA; Kokosadze NV; Gorodetskiĭ VR; Kovrigina AM; Kondrat'eva TT; Mitrikov BV; Gaĭduk IV; Safonova TN; Simonova MV; Radenska-Lopovok SG; Varlamova EIu
Ter Arkh; 2009; 81(6):20-7. PubMed ID: 19663187
[TBL] [Abstract][Full Text] [Related]
37. [Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases].
Jia N; Tang FL
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(39):2786-8. PubMed ID: 20137605
[TBL] [Abstract][Full Text] [Related]
38. Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.
Goules AV; Tatouli IP; Moutsopoulos HM; Tzioufas AG
Arthritis Rheum; 2013 Nov; 65(11):2945-53. PubMed ID: 24166794
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of cryoglobulins, protein electrophoresis, and serum immunoglobulins for lymphoma development in patients with Sjögren's syndrome. A retrospective cohort study.
Kimman J; Bossuyt X; Blockmans D
Acta Clin Belg; 2018 Jun; 73(3):169-181. PubMed ID: 28971741
[TBL] [Abstract][Full Text] [Related]
40. [Long-term follow-up of 43 patients with Sjögren's syndrome].
Cui G; Sugai S; Ogawa Y; Takeshita S; Masaki Y; Fukutoku M
Ryumachi; 1997 Dec; 37(6):770-80. PubMed ID: 9492564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
